Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A zero-based budget assigns every dollar a job, helping low-income households direct funds toward essentials, debt payoff, and savings.
22,326 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
XRP has faced big swings, yet Ripple’s developments could shift the long-term outlook. This guide maps out scenarios ...
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
SpaceX signals a potential $75 billion IPO, elevating CFO Bret Johnsen to the center of a new phase focused on govern...
A wedding venue owner took more than $1 million from unsuspecting couples and investors. This article uncovers how th...
February can be a pivotal month for tech investing. This guide reveals three top tech stocks february to consider, pl...
A security breach at a leading crypto gift card platform on March 1 has security researchers weighing North Korean-li...
Regulated XRP ETFs have opened a convenient on-ramp to Ripple exposure. This story breaks down how (ripple) beginners...
A sudden pullback in a high-profile space stock captured headlines. This article breaks down the factors behind intui...
SpaceX is fueling ambitious AI bets with a massive cash runway. This article weighs that plan against two established...
Crypto markets cooled as inflation persisted and rate-cut hopes dimmed. Now, a different tech story is driving big ga...
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...